Cover Image

Recent advances targeting CCR5 for cancer and its role in immuno-oncology

Experiments of nature have revealed the peculiar importance of the G-protein–coupled receptor, C-C chemokine receptor type 5 (CCR5), in human disease since ancient times. The resurgence of interest in heterotypic signals in the onset and progression of tumorigenesis has led to the current focus on C...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiao, Xuanmao (Author) , Nawab, Omar (Author) , Patel, Tejal (Author) , Kossenkov, Andrew V. (Author) , Halama, Niels (Author) , Jäger, Dirk (Author) , Pestell, Richard G. (Author)
Format: Article (Journal)
Language:English
Published: July 10, 2019
In: Cancer research
Year: 2019, Volume: 79, Issue: 19, Pages: 4801-4807
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-19-1167
Online Access:Verlag, Volltext: https://doi.org/10.1158/0008-5472.CAN-19-1167
Verlag: https://cancerres.aacrjournals.org/content/79/19/4801
Get full text
Author Notes:Xuanmao Jiao, Omar Nawab, Tejal Patel, Andrew V. Kossenkov, Niels Halama, Dirk Jaeger, and Richard G. Pestell

MARC

LEADER 00000caa a2200000 c 4500
001 1685870287
003 DE-627
005 20230427132840.0
007 cr uuu---uuuuu
008 191218s2019 xx |||||o 00| ||eng c
024 7 |a 10.1158/0008-5472.CAN-19-1167  |2 doi 
035 |a (DE-627)1685870287 
035 |a (DE-599)KXP1685870287 
035 |a (OCoLC)1341286492 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jiao, Xuanmao  |e VerfasserIn  |0 (DE-588)1201740916  |0 (DE-627)1685869246  |4 aut 
245 1 0 |a Recent advances targeting CCR5 for cancer and its role in immuno-oncology  |c Xuanmao Jiao, Omar Nawab, Tejal Patel, Andrew V. Kossenkov, Niels Halama, Dirk Jaeger, and Richard G. Pestell 
264 1 |c July 10, 2019 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.12.2019 
520 |a Experiments of nature have revealed the peculiar importance of the G-protein–coupled receptor, C-C chemokine receptor type 5 (CCR5), in human disease since ancient times. The resurgence of interest in heterotypic signals in the onset and progression of tumorigenesis has led to the current focus on CCR5 as an exciting new therapeutic target for metastatic cancer with clinical trials now targeting breast and colon cancer. The eutopic expression of CCR5 activates calcium signaling and thereby augments regulatory T cell (Treg) differentiation and migration to sites of inflammation. The misexpression of CCR5 in epithelial cells, induced upon oncogenic transformation, hijacks this migratory phenotype. CCR5 reexpression augments resistance to DNA-damaging agents and is sufficient to induce cancer metastasis and “stemness”. Recent studies suggest important cross-talk between CCR5 signaling and immune checkpoint function. Because CCR5 on Tregs serves as the coreceptor for human immunodeficiency virus (HIV) entry, CCR5-targeted therapeutics used in HIV, [small molecules (maraviroc and vicriviroc) and a humanized mAb (leronlimab)], are now being repositioned in clinical trials as cancer therapeutics. As CCR5 is expressed on a broad array of tumors, the opportunity for therapeutic repositioning and the rationale for combination therapy approaches are reviewed herein. 
700 1 |a Nawab, Omar  |e VerfasserIn  |4 aut 
700 1 |a Patel, Tejal  |e VerfasserIn  |4 aut 
700 1 |a Kossenkov, Andrew V.  |e VerfasserIn  |4 aut 
700 1 |a Halama, Niels  |d 1977-  |e VerfasserIn  |0 (DE-588)13087325X  |0 (DE-627)507228723  |0 (DE-576)251045706  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Pestell, Richard G.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cancer research  |d Philadelphia, Pa. : AACR, 1941  |g 79(2019), 19, Seite 4801-4807  |h Online-Ressource  |w (DE-627)325489955  |w (DE-600)2036785-5  |w (DE-576)094502226  |x 1538-7445  |7 nnas  |a Recent advances targeting CCR5 for cancer and its role in immuno-oncology 
773 1 8 |g volume:79  |g year:2019  |g number:19  |g pages:4801-4807  |g extent:7  |a Recent advances targeting CCR5 for cancer and its role in immuno-oncology 
856 4 0 |u https://doi.org/10.1158/0008-5472.CAN-19-1167  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://cancerres.aacrjournals.org/content/79/19/4801  |x Verlag 
951 |a AR 
992 |a 20191218 
993 |a Article 
994 |a 2019 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 6 
998 |g 13087325X  |a Halama, Niels  |m 13087325X:Halama, Niels  |d 910000  |d 910100  |d 50000  |e 910000PH13087325X  |e 910100PH13087325X  |e 50000PH13087325X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 5 
999 |a KXP-PPN1685870287  |e 3566384488 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1158/0008-5472.CAN-19-1167"],"eki":["1685870287"]},"relHost":[{"part":{"volume":"79","extent":"7","issue":"19","text":"79(2019), 19, Seite 4801-4807","year":"2019","pages":"4801-4807"},"language":["eng"],"corporate":[{"display":"American Association for Cancer Research","role":"isb"}],"id":{"eki":["325489955"],"issn":["1538-7445"],"zdb":["2036785-5"]},"recId":"325489955","physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["American Association for Cancer Research"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Recent advances targeting CCR5 for cancer and its role in immuno-oncologyCancer research","title":[{"title":"Cancer research","title_sort":"Cancer research"}],"note":["Gesehen am 31.03.25","Fortsetzung der Druck-Ausgabe"],"pubHistory":["Volume 1, issue 1 (1 January 1941)-"],"origin":[{"dateIssuedKey":"1941","publisher":"AACR","dateIssuedDisp":"1941-","publisherPlace":"Philadelphia, Pa."}]}],"recId":"1685870287","name":{"displayForm":["Xuanmao Jiao, Omar Nawab, Tejal Patel, Andrew V. Kossenkov, Niels Halama, Dirk Jaeger, and Richard G. Pestell"]},"physDesc":[{"extent":"7 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"July 10, 2019","dateIssuedKey":"2019"}],"note":["Gesehen am 18.12.2019"],"title":[{"title_sort":"Recent advances targeting CCR5 for cancer and its role in immuno-oncology","title":"Recent advances targeting CCR5 for cancer and its role in immuno-oncology"}],"language":["eng"],"person":[{"given":"Xuanmao","role":"aut","display":"Jiao, Xuanmao","family":"Jiao"},{"family":"Nawab","display":"Nawab, Omar","role":"aut","given":"Omar"},{"display":"Patel, Tejal","family":"Patel","role":"aut","given":"Tejal"},{"display":"Kossenkov, Andrew V.","family":"Kossenkov","given":"Andrew V.","role":"aut"},{"family":"Halama","display":"Halama, Niels","role":"aut","given":"Niels"},{"display":"Jäger, Dirk","family":"Jäger","given":"Dirk","role":"aut"},{"display":"Pestell, Richard G.","family":"Pestell","given":"Richard G.","role":"aut"}]} 
SRT |a JIAOXUANMARECENTADVA1020 

Similar Items